SCHEMBL22763864

SCHEMBL22763864

c1ccc(-c2ccc(-c3nc(-c4ccc5c(c4)oc4cccc(-c6ccccc6)c45)nc(-c4cccc5oc6ccccc6c45)n3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.39
BACE1 P56817 1/20 0.38
MAPT P10636 5/20 0.37
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
HPGD P15428 3/20 0.37
TSHR P16473 2/20 0.37
ATM Q13315 2/20 0.37
TP53 P04637 1/20 0.37
NFKB1 P19838 1/20 0.37
MAPK1 P28482 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
POLB P06746 1/20 0.36
TTR P02766 1/20 0.36
MMP12 P39900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24217265 1.00 HCRTR1 (0.39) HCRTR1BACE1MAPTALDH1A1KDM4E
SCHEMBL24217263 0.99 HCRTR1 (0.40) HCRTR1BACE1MAPTALDH1A1KDM4E
SCHEMBL23823729 0.97 HCRTR1 (0.40) HCRTR1BACE1MAPTALDH1A1KDM4E
SCHEMBL23821247 0.97 HCRTR1 (0.39) HCRTR1BACE1MAPTALDH1A1KDM4E
SCHEMBL22763861 0.96 HCRTR1 (0.41) HCRTR1BACE1MAPTALDH1A1KDM4E
SCHEMBL21148512 0.96 HCRTR1 (0.40) HCRTR1BACE1MAPTALDH1A1KDM4E
SCHEMBL25645658 0.96 HCRTR1 (0.40) HCRTR1BACE1MAPTALDH1A1KDM4E
SCHEMBL21108831 0.96 HCRTR1 (0.40) HCRTR1BACE1MAPTALDH1A1KDM4E
SCHEMBL22763866 0.96 HCRTR1 (0.40) HCRTR1BACE1MAPTALDH1A1KDM4E
SCHEMBL26686954 0.96 ALDH1A1 (0.36) HCRTR1BACE1MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024079725-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY 삼성에스디아이 주식회사 2024-04-18 WO disclosed
US-20220399508-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2022-12-15 US disclosed
US-20200388766-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2020-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200388766-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE AND DISPLAY DEVICE OCIAD2, OR10J3, OCIAD1 HCRTR1 225/4885BACE1 3345/4885MAPT 607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.